Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Open Text Corporation — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Open Text Corporation trades at $23.98 (market cap $5.80B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is the larger of the two by market cap, and Open Text Corporation pays a 4.67% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | OTEX | |
|---|---|---|
Market Cap | $9.43B | $5.80B |
Sector | Health | Technology |
52-Week High | $356.25 | $39.69 |
52-Week Low | $241.71 | $20.01 |
Enterprise Value | $9.18B | $10.81B |
Dividend Yield | — | 4.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Open Text Corporation (OTEX) trades at $24.94, down 2.81% in the last session, with a bullish technical signal from moving averages and strong support at $24. The company reported Q2 2026 EPS of $1.23, beating estimates, and maintains robust profitability with a 73.74% gross margin. Recent news highlights cloud revenue growth and a $105 million AI investment in Europe, signaling strategic expansion.
OTEX presents a value opportunity with a low P/E of 9.58 and a consensus price target of $29.33, implying 17.6% upside. Risks include high long-term debt of $6.34 billion and competitive pressures in software. Analyst sentiment is mixed, with 42% buy ratings, but earnings beats and dividend stability support a constructive outlook for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
